Table 2 Clinical, laboratory and radiological data among enrolled patients.
From: COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma
COVID-19 only (n = 400) | CAM (n = 33) | P value | |
|---|---|---|---|
Heart rate (b/m) | 86.91 ± 8.25 | 85.67 ± 8.82 | 0.41 |
Temperature (ºC) | 38.29 ± 0.68 | 38.27 ± 0.69 | 0.95 |
Respiratory rate (c/m) | 28.75 ± 1.67 | 29.06 ± 2.26 | 0.32 |
Baseline hypoxemia | 328 (82%) | 28 (84.8%) | 0.44 |
RBS (mg/dl) | 140 (90–298) | 210 (121–240) | < 0.001 |
Leucocytes (103/µl) | 13 (1–34) | 10 (6–16) | < 0.001 |
Lymphocytes (103/µl) | 1.30 (0.20–4) | 1.2 (0.30–3) | 0.97 |
RDW (%) | 14.83 ± 2.81 | 15.73 ± 3.33 | 0.08 |
Hemoglobin (mg/dl) | 13.37 ± 1.39 | 12.11 ± 1.54 | < 0.001 |
Platelets (103/µl) | 205.87 ± 60.56 | 221.39 ± 76.26 | 0.16 |
Raised ESR | 48 (12%) | 18 (54.5%) | < 0.001 |
CRP (mg/dl) | 32 (0.50–119) | 24 (4–180) | 0.27 |
d-dimer (ng/dl) | 0.60 (0.03–76) | 0.50 (0.10–95) | 0.60 |
SOFA score | 5 (2–17) | 5 (2–18) | 0.39 |
Chest radiologya | |||
Consolidation | 116 (29%) | 0 | < 0.001 |
GGO | 160 (40%) | 33 (100%) | |
GGO and consolidation | 124 (31%) | 0 | |
Severity of COVID-19 | |||
Moderate | 200 (50%) | 7 (21.2%) | < 0.001 |
Severe | 160 (40%) | 16 (48.5%) | |
Life threatening | 40 (10%) | 10 (30.3%) | |